CANNAPHARMARX, INC. Proceeds from Notes Payable
CANNAPHARMARX, INC. (CPMD) reported Proceeds from Notes Payable of $0 for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-31.
Financial Statements › Cash Flow › Financing Activities
us-gaap:ProceedsFromNotesPayable · last filed 2026-03-31
- CANNAPHARMARX, INC. proceeds from notes payable for the quarter ending 2025-12-31 was $0.00.
- CANNAPHARMARX, INC. proceeds from notes payable for the quarter ending 2025-09-30 was $0.00, a 100.00% decline year-over-year.
- CANNAPHARMARX, INC. proceeds from notes payable for the quarter ending 2024-12-31 was -$271.24K.
- CANNAPHARMARX, INC. proceeds from notes payable for the quarter ending 2024-09-30 was $1.60M.
- CANNAPHARMARX, INC. proceeds from notes payable for fiscal 2025 was $0.00, a 100.00% decline from fiscal 2024.
- CANNAPHARMARX, INC. proceeds from notes payable for fiscal 2024 was $1.55M.
- CANNAPHARMARX, INC. proceeds from notes payable for fiscal 2023 was $0.00.
| Period end | Proceeds from Notes Payable 3 month | Proceeds from Notes Payable 6 month | Proceeds from Notes Payable 9 month | Proceeds from Notes Payable 9 month as first filed | Proceeds from Notes Payable 12 month |
|---|---|---|---|---|---|
| 2025-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | $0.00 derived: sum of 2 quarters · filed 2026-03-31 | $0.00 10-K · filed 2026-03-31 | ||
| 2025-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-14 | $0.00 10-Q · filed 2025-11-14 | |||
| 2025-06-30 | $0.00 10-Q · filed 2025-08-14 | ||||
| 2024-12-31 | -$271.24K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | $1.33M derived: sum of 2 quarters · filed 2026-03-31 | $1.48M derived: sum of 3 quarters · filed 2026-03-31 | $1.55M 10-K · filed 2026-03-31 | |
| 2024-09-30 | $1.60M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-14 | $1.75M derived: sum of 2 quarters · filed 2025-11-14 | $1.82M 10-Q · filed 2025-11-14 | $1.82M derived: sum of 4 quarters · filed 2025-11-14 | |
| 2024-06-30 | $152.77K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-14 | $220.00K 10-Q · filed 2025-08-14 | $220.00K derived: sum of 3 quarters · filed 2025-08-14 | $6.25K derived: sum of 4 quarters · filed 2025-08-14 | |
| 2024-03-31 | $67.23K 10-Q · filed 2024-06-25 | $67.23K derived: sum of 2 quarters · filed 2025-04-10 | -$146.52K derived: sum of 3 quarters · filed 2025-04-10 | -$86.52K derived: sum of 4 quarters · filed 2025-04-10 | |
| 2023-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-04-10 | -$213.75K derived: sum of 2 quarters · filed 2025-04-10 | -$153.75K derived: sum of 3 quarters · filed 2025-04-10 | $0.00 10-K · filed 2025-04-10 | |
| 2023-09-30 | -$213.75K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-14 | -$153.75K derived: sum of 2 quarters · filed 2024-11-14 | $0.00 10-Q · filed 2024-11-14 | $213.75K 10-Q · filed 2023-11-17 | |
| 2023-06-30 | $60.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-10-13 | $213.75K 10-Q · filed 2023-10-13 | |||
| 2023-03-31 | $153.75K 10-Q · filed 2024-06-25 | ||||
| 2022-09-30 | $694.95K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-17 | $694.95K derived: sum of 2 quarters · filed 2023-11-17 | $694.95K 10-Q · filed 2023-11-17 | ||
| 2022-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2023-10-13 | $0.00 10-Q · filed 2023-10-13 | |||
| 2022-03-31 | $0.00 10-Q · filed 2023-09-22 |